跳至主要内容
临床试验/NCT06548776
NCT06548776已完成不适用

Establishing Daily Applicable Parameters for Using Magnetic Resonance Spectroscopy of Spinal Cord

M.D. Anderson Cancer Center2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2024年9月4日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
10
试验地点
2
主要终点
Safety and Adverse Events (AEs)

研究概览

简要总结

To learn if MRS can effectively assess spinal cord lesions.

详细描述

Primary Objective:

Establish the feasibility and spectrum of MRS for adult patients while mapping the total spine spectrum at short TEs to allow for future comparison with patients to assess spinal cord lesions malignant potential and grade.

Secondary Objective:

Test success of the spectrum by implementing the protocol on 3 low volume LMD receiving LMD receiving CSI. This will allow us to test reproducibility of the protocol and test effect of radiation on spinal cord at different time frames. This will serve as secondary data for subsequent trials targeting functional statues after radiation and tumor grading predictability of MRS.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Volunteers:
  • Adults > 18 years
  • Healthy with no malignancy, demyelinating disease, back pain, degenerative disease, or spinal cord lesions.
  • Consent able patients.
  • Patients with low volume LMD to receive treatment CNS radiation:
  • Adults > 18 years old.
  • MR or CSF with evidence of LMD.
  • Patients to receive CSI as part of standard treatment of LMD disease.
  • Consent able patients, willingness and ability to comply with the study procedures.
  • No spinal cord lesions only LMD disease
  • Recruitment by radiation oncology faculty in consultation with Dr. De. . .

排除标准

  • Volunteers:
  • Age < 18 years
  • Pregnant or breastfeeding individuals.
  • History of cancer.
  • History of spinal cord lesions including malignant, demyelinating, or inflammatory.
  • History of prior spinal surgery.
  • History of implantable devices.
  • History of MR claustrophobia.
  • Degenerative disease or spinal/back pain including myelopathy and radiculopathy.
  • Scoliosis.
  • Patients with LMD:
  • Age < 18 years
  • History of spinal cord lesions including malignant, demyelinating, or inflammatory.
  • History of prior spinal surgery.
  • History of implantable devices.
  • History of MR claustrophobia.
  • Degenerative disease or spinal/back pain including myelopathy and radiculopathy.
  • Scoliosis.

研究组 & 干预措施

Patients

Experimental

Participants will be recruited from DI volunteer pool to implement MRS spine on.

干预措施: Magnetic Resonance Spectroscopy (MRS) Scan (Diagnostic Test)

Healthy Volunteers

Experimental

Participants will be recruited from DI volunteer pool to implement MRS spine on.

干预措施: Magnetic Resonance Spectroscopy (MRS) Scan (Diagnostic Test)

结局指标

主要结局

Safety and Adverse Events (AEs)

时间窗: Through study completion; an average of 1 year.

Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验